• Publications
  • Influence
Medicines Regulation in Africa: Current State and Opportunities
Sound regulatory systems are critical for protecting public health against use of medical products which do not meet international standards of quality, safety and efficacy. This review provides aExpand
  • 38
  • 2
` The African Medicines Regulatory Harmonization Initiative: Progress to Date
The African Medicines Regulatory Harmonization Initiative (AMRH) has contributed to reduce marketing authorization timelines in East African Community and the Southern African Development CommunityExpand
  • 13
  • 2
Access to colorectal cancer (CRC) chemotherapy and the associated costs in a South African public healthcare patient cohort
Abstract Reported colorectal cancer incidence is increasing in South Africa and places strain on the public healthcare system especially as costs associated with chemotherapy globally are rising. TheExpand
  • 2
National medicines regulatory authorities financial sustainability in the East African Community
Introduction Adequate and sustainable funding of national medicine regulatory agencies (NMRAs) is key for assurance of quality, safety and efficacy of medical products circulating in a market. TheExpand
  • 1
  • PDF
Primary healthcare delivery models for uninsured low-income earners during the transition to National Health Insurance: Perspectives of private South African providers.
BACKGROUND The proposed National Health Insurance (NHI) system aims to re-engineer primary healthcare (PHC) provision in South Africa, with strategic purchasing of services from both private andExpand
  • 2
  • PDF
Colorectal Cancer (CRC) treatment and associated costs in the public sector compared to the private sector in Johannesburg, South Africa
Background South Africa’s divided healthcare system is believed to be inequitable as the population serviced by each sector and the treatment received differs while annual healthcare expenditure isExpand
Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community
Background Limited capacity to regulate medical products is associated with circulation of products which do not meet standards of quality, safety and efficacy with negative public health andExpand